000 03598nam a22004335i 4500
999 _c6837
_d6837
001 6837
003 ES-MaUEC
005 20201203160821.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 200229s2020 si | o |||| 0|eng d
020 _a9789811523656
024 7 _a10.1007/978-981-15-2365-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC903
_b.R43 2020 EB
245 0 0 _aRecent Advances of Sarcopenia and Frailty in CKD
_cedited by Akihiko Kato, Eiichiro Kanda, Yoshihiko Kanno.
250 _aFirst edition 2020
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2020.
300 _a1 recurso en línea (VIII, 245 páginas)
_b55 ilustraciones, 25 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _a1 Epidemiology of sarcopenia and frailty in CKD -- 2 Molecular mechanism of muscle wasting in CKD -- 3 Protein Energy Wasting in Chronic Kidney Disease -- 4 Benefit and risk of exercise training in CKD patients -- 5 "Frailty in patients with pre-dialysis CKD; Toward successful aging of the elderly patients transitioning to dialysis in Japan" -- 6 Exercise interventions in dialysis patients -- 7 Exercise intervention for kidney transplant recipients: recent progress and remaining issues -- 8 Role of nutrition and rehabilitation in the prevention and management of sarcopenia and frailty -- 9 Nutritional interventions in elderly pre-dialysis patients -- 10 Nutritional interventions in dialysis patients.-11 Pharmacological intervention for sarcopenia in CKD -- 12 Oral Health Management for the Prevention of Sarcopenia and Frailty -- 13 Frailty and cognitive impairment in CKD -- 14 Polypharmacy and frailty in CKD -- 15 Anemia management and QOL and frailty in CKD.
520 3 _aThis book highlights recent advances in our understanding of sarcopenia and frailty in CKD. The prevalence of sarcopenia and frailty increases substantially as CKD progresses, and experimental studies have demonstrated the pivotal role of accumulated uremic toxin in the development of muscle wasting. Further, sarcopenia and frailty are associated with falls, bone fractures, cognitive impairment, and poor survival prognoses, especially in elderly CKD patients. The syndromes are also related to the risk of end-stage kidney disease. This book provides readers with a deeper understanding of the prevention and management of sarcopenia and frailty in CKD patients to improve their renal and overall health, and suggests directions for future basic and clinical research.
650 7 _2embne
_9168885
_aRiñones
_xEnfermedades
700 1 _aKato, Akihiko.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aKanda, Eiichiro.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aKanno, Yoshihiko.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789811523649
776 0 8 _iPrinted edition:
_z9789811523663
776 0 8 _iPrinted edition:
_z9789811523670
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-2365-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_zSI